Implantable cardioverter‐defibrillators (ICDs) improve survival when used as primary or
secondary prevention therapy in patients with a broad spectrum of disorders associated with …

Despite the clinical benefit of implantable cardioverter defibrillator (ICD), there is a high
frequency of inappropriate ICD therapy associated with impaired quality of life, unwanted …

Since the widespread implementation of implantable cardioverter-defibrillators (ICDs), their
effectiveness in various situations has become well-established. However, despite many …

Background Recent evidence has revealed the utility of prolonged arrhythmia detection
duration and increased rate cutoff to reduce implantable cardioverter-defibrillator (ICD) …

Implantable cardioverter defibrillators (ICDs) have been shown to provide a survival benefit
in patients at high risk of sudden cardiac death. A major problem associated with ICD …

Implantable cardioverter-defibrillators (ICDs) reduce sudden cardiac death risk and improve
survival in patients with a history of life-threatening arrhythmia or cardiac arrest (secondary …

Inappropriate shock is a frequently seen clinical problem despite advanced technologies
used in modern implantable cardioverter-defibrillator (ICD) devices. Our aim was to …

Background The implantable cardioverter–defibrillator (ICD) is highly effective in reducing
mortality among patients at risk for fatal arrhythmias, but inappropriate ICD activations are …

The use of implantable cardioverter-defibrillators (ICDs) as a primary prevention therapy has
been shown to reduce mortality in patients after cardiac arrest and also with left ventricular …

Life-saving shocks are the raisons d'être of implantable cardioverter-defibrillators (ICDs).
Paradoxically, shocks also cause much of the morbidity associated with ICDs. Consistently …